http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-360545-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_411b6eedc075072219da342224d2dc97 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-232 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-232 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-00 |
filingDate | 1997-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1999-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69034c0897a0b64dfc442154d29b02e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c73aec7bd3ada04b95903705725eabb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_735ec05007fcff0b08f453d89a7eb9ae |
publicationDate | 1999-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | TW-360545-B |
titleOfInvention | Dermatologic preparation |
abstract | A dermatologic preparation which is reduced in side effects, has excellent percutaneous absorbability, and contains as the active ingredient an unsaturated fatty acid, which is a triglyceride represented by general formula (1), wherein one or two R1, R2, and R3 each represents a residue of a long-chain unsaturated fatty acid and the remainder represent(s) residue(s)of a medium-chain fatty acid. The triglyceride is preferably represented by formula (1) wherein one of R1, R2, and R3 represents a residue of along-chain unsaturated fatty acid and the remainder represent(s) residue(s) of a medium-chain fatty acid. The long-chain unsaturated fatty acid is selected from the group consisting of eicosapentaenoic acid, docosahexaenoic acid, docosapentaenoic acid, arachidonic acid, α-linolenic acid, γ-linolenic acid, linoleic acid, and dihomo-γ-linolenic acid. The most desirable is the eicosapentaenoic acid residue or docosahexaenoic acid residue. The triglyceride is one obtained from a long-chain unsaturated fatty acid and/or a derivative thereof each having a purity of preferably 90% or higher, more preferably 95% or higher. |
priorityDate | 1996-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.